SLC30A7
protein-codingsolute carrier family 30 member 7, the group of Solute carrier family 30
Gene summary
Zinc functions as a cofactor for numerous enzymes, nuclear factors, and hormones and as an intra- and intercellular signal ion. Members of the zinc transporter (ZNT)/SLC30 subfamily of the cation diffusion facilitator family, such as SLC30A7, permit cellular efflux of zinc (Seve et al., 2004 [PubMed 15154973]).[supplied by OMIM, Mar 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~100.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0018772
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018772
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Endocrine; Hematologic
Intervention: Allergy/Immunology/Infectious; Endocrine; Hematologic
Rationale: The condition can include hormone deficiencies, and awareness may allow medical management; Due to mineral abnormalities, supplementation has been described as necessary; The condition may involve bone marrow failure, including neutropenia and thrombocytopenia, and the need for interventions such as RBC transfusions has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC30A7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_133496.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 1 | 7 | ||
| missense | 1 | 56 | 2 | 1 | 60 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 3 | 57 | 7 | 2 | 70 |
Highest pathogenic variant AF is 0.000011628797
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_598003.2 | 11 | MANE Select | |
| Ensembl | ENSP00000350278.4 | 11 | MANE Select | |
| RefSeq | NP_001138356.1 | 11 | Standard | |
| Ensembl | ENSP00000359129.4 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Zinc homeostasis
- Peptide hormone metabolism
- Metabolism of proteins
- Transport of bile salts and organic acids, metal ions and amine compounds
- SLC-mediated transmembrane transport
Biological Process
- zinc ion transport
- sequestering of zinc ion
- cation transmembrane transport
Molecular Function
- cation transmembrane transporter activity
Cellular Component
- cytoplasm
- Golgi apparatus
- integral component of membrane
- cytoplasmic vesicle
- vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370112
- Coding exons
- 11
- Length
- 85678
- Individuals with no LoFs
- 125712
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 125748
- p
- 0.000143
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.467 | 182 | 201 | 0.907 | 0.00000921 | 2485 |
| Missense (PolyPhen) | 72 | 83.253 | 0.86483 | 1068 | ||
| Synonymous | -0.435 | 79 | 74.2 | 1.06 | 0.00000393 | 718 |
| Loss of Function | 1.49 | 13 | 20.2 | 0.643 | 8.56e-7 | 248 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.00010 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Seems to facilitate zinc transport from the cytoplasm into the Golgi apparatus. Partly regulates cellular zinc homeostasis. Required with ZNT5 for the activation of zinc- requiring enzymes, alkaline phosphatases (ALPs). Transports zinc into the lumens of the Golgi apparatus and the vesicular compartments where ALPs locate, thus, converting apoALPs to holoALPs. Required with ZNT5 and ZNT6 for the activation of TNAP (By similarity). {ECO:0000250, ECO:0000269|PubMed:15276077, ECO:0000269|PubMed:15994300}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- LoFtool
- 0.740
- RVIS EVS
- -0.69
- RVIS percentile EVS
- 14.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.786
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |